Detalhe da pesquisa
1.
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
Eur J Haematol
; 106(6): 808-820, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638218
2.
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosomeâpositive leukemias.
Leuk Res
; 111: 106690, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673442